Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases

Liska V, Holubec L Jr, Treska V, Skalicky T, Sutnar A, Kormunda S, Pesta M, Finek J, Rousarova M, Topolcan O.

. 2007 ; 27 (4C) : 2861-2864.

Jazyk angličtina Země Řecko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10000818

Grantová podpora
NR7905 MZ0 CEP - Centrální evidence projektů
NR8301 MZ0 CEP - Centrální evidence projektů

BACKGROUND: The authors present a statistical analysis of the dynamics of tumour markers and compare these with single serum levels in patients before and after liver surgery for colorectal liver metastases (CLM). PATIENTS AND METHODS: The serum levels of tumor markers conventionally used in clinical practice (CA19-9, CEA, CA72-4) and markers informing of the proliferation activity of malignancy (TKI TPA, TPS) were statistically analysed. The authors studied 144 patients who underwent liver surgery for colorectal liver metastases between September 1999 and June 2005. Serum levels of tumor markers before surgery (maximally two weeks before the operation), after surgery (maximally one month after the operation - usually on the day of dismission), six months (+/- one month) and twelve months after the surgery (+/- one month) were determined. The Log Rank test and the Wilcoxon test were used for statistical evaluation. The survival rate and disease-free intervals (DFI) were computed using the Kaplan-Meier method. RESULTS: The statistical analysis of tumour marker dynamic after liver surgery (speed and power of recurrence) supported the dynamics of CA 19-9 and CEA as excellent prognostic factors of early recurrence of CLM in contrast to proliferative tumor markers. CONCLUSION: The results of the study suggest the importance of tumour markers for the prediction of a short survival rate or DFI. This approach would be very helpful for the planning of palliative oncological treatment for patients with liver malignancies that cannot be treated by surgical therapy. Current patients with a high tendency of recurrence of CLM after liver surgery should be followed up more thoroughly to increase the possibility of successful reoperation.

000      
00000naa 2200000 a 4500
001      
bmc10000818
003      
CZ-PrNML
005      
20131010100534.0
008      
100114s2007 gr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Liška, Václav, $d 1978- $7 xx0073943
245    10
$a Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases / $c Liska V, Holubec L Jr, Treska V, Skalicky T, Sutnar A, Kormunda S, Pesta M, Finek J, Rousarova M, Topolcan O.
314    __
$a Department of Surgery, University Hospital Pilsen, Charles University Prague, Alej svobody 80, 323 00 Pilsen, Czech Republic. Vena.liska@seznam.cz
520    9_
$a BACKGROUND: The authors present a statistical analysis of the dynamics of tumour markers and compare these with single serum levels in patients before and after liver surgery for colorectal liver metastases (CLM). PATIENTS AND METHODS: The serum levels of tumor markers conventionally used in clinical practice (CA19-9, CEA, CA72-4) and markers informing of the proliferation activity of malignancy (TKI TPA, TPS) were statistically analysed. The authors studied 144 patients who underwent liver surgery for colorectal liver metastases between September 1999 and June 2005. Serum levels of tumor markers before surgery (maximally two weeks before the operation), after surgery (maximally one month after the operation - usually on the day of dismission), six months (+/- one month) and twelve months after the surgery (+/- one month) were determined. The Log Rank test and the Wilcoxon test were used for statistical evaluation. The survival rate and disease-free intervals (DFI) were computed using the Kaplan-Meier method. RESULTS: The statistical analysis of tumour marker dynamic after liver surgery (speed and power of recurrence) supported the dynamics of CA 19-9 and CEA as excellent prognostic factors of early recurrence of CLM in contrast to proliferative tumor markers. CONCLUSION: The results of the study suggest the importance of tumour markers for the prediction of a short survival rate or DFI. This approach would be very helpful for the planning of palliative oncological treatment for patients with liver malignancies that cannot be treated by surgical therapy. Current patients with a high tendency of recurrence of CLM after liver surgery should be followed up more thoroughly to increase the possibility of successful reoperation.
650    _2
$a financování organizované $7 D005381
650    _2
$a kolorektální nádory $x krev $x patologie $7 D015179
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x chirurgie $x krev $x sekundární $7 D008113
650    _2
$a lokální recidiva nádoru $x krev $x patologie $7 D009364
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a nádorové biomarkery $x krev $7 D014408
700    1_
$a Holubec, Luboš, $d 1972- $7 xx0068645
700    1_
$a Třeška, Vladislav, $d 1957- $7 jn20000402436
700    1_
$a Skalický, Tomáš, $d 1965- $7 xx0017169
700    1_
$a Sutnar, Alan $7 xx0081862
700    1_
$a Kormunda, Stanislav $7 xx0103970
700    1_
$a Pešta, Martin, $d 1976- $7 xx0073915
700    1_
$a Fínek, Jindřich, $d 1957- $7 xx0026897
700    1_
$a Roušarová, Milena. $7 jo2015860324
700    1_
$a Topolčan, Ondřej, $d 1943- $7 jn20000402383
773    0_
$w MED00000478 $t Anticancer research $g Roč. 27, č. 4C (2007), s. 2861-2864 $x 0250-7005
910    __
$a ABA008 $b x $y 8 $z 0
990    __
$a 20090310084605 $b ABA008
991    __
$a 20131010101057 $b ABA008
999    __
$a ok $b bmc $g 703546 $s 565986
BAS    __
$a 3
BMC    __
$a 2007 $b 27 $c 4C $d 2861-2864 $i 0250-7005 $m Anticancer research $x MED00000478
GRA    __
$a NR7905 $p MZ0
GRA    __
$a NR8301 $p MZ0
LZP    __
$a 2010-b1/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...